A particular prostate cell that researchers had hitherto not taken into account could be the trigger point of malignant prostate cancer, new studies reveal.
Howard Hughes Medical Institute (HHMI) researcher Owen N. Witte and his colleagues at the University of California, Los Angeles (UCLA) found that the somewhat overlooked prostate basal cell could spawn tumours in the prostate gland.
Advertisement
Previous research from Witte's laboratory showed that, in mice, basal cells, not luminal cells, acquired the genetic damage required to turn cancerous.
To extend these results to humans, Witte and colleagues at UCLA developed new techniques to study human prostate tissue and its propensity to cause cancer.
![Quiz on Prostate Cancer]( "Quiz on Prostate Cancer")
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it's too late. This quiz tests your knowledge on prostate cancer, its diagnosis and treatment options and is as mandatory for men as the screening tests mentioned here are!
Over a period of several years, the team first identified a series of unique cell surface markers that help researchers distinguish luminal cells from basal cells. They then used these markers to separate the two cell types in samples of human prostate tissue.
Patients undergoing prostate cancer surgery agreed to donate the tissue for research studies. In those operations, a surgeon typically removes healthy tissue along with the cancer. The tissue from those operations was given to Witte's team to provide the material they needed for their studies.
After separating luminal cells from basal cells, the researchers prodded all of the cells to become cancerous by introducing three genes known to promote prostate cancer. A virus was used to deliver the genes-called AKT, ERG, and AR - into luminal cells and basal cells.
The researchers then separately engrafted the transformed luminal cells and the transformed basal cells into mice.
In the meantime, though, the basal cell grafts had gone through three stages: They had grown into prostate-like tubules, transformed into damaged pre-cancerous cells, and then turned malignant and formed tumours.
"In our experimental model, basal cells show the ability to form the disease that looks like what we see in humans," says Goldstein.
The engrafted basal cells - after turning cancerous - also looked very much like luminal cells, as in clinical tumour samples. Witte says that this suggests that on their way to becoming cancerous, basal cells grow into more luminal-like cells.
The study has been unveiled in the July 30, 2010 issue of Science.
Source: ANI
Quiz on Prostate Cancer
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it's too late. This quiz tests your knowledge on prostate cancer, its diagnosis and treatment options and is as mandatory for men as the screening tests mentioned here are!
Advertisement
Over a period of several years, the team first identified a series of unique cell surface markers that help researchers distinguish luminal cells from basal cells. They then used these markers to separate the two cell types in samples of human prostate tissue.
Patients undergoing prostate cancer surgery agreed to donate the tissue for research studies. In those operations, a surgeon typically removes healthy tissue along with the cancer. The tissue from those operations was given to Witte's team to provide the material they needed for their studies.
After separating luminal cells from basal cells, the researchers prodded all of the cells to become cancerous by introducing three genes known to promote prostate cancer. A virus was used to deliver the genes-called AKT, ERG, and AR - into luminal cells and basal cells.
The researchers then separately engrafted the transformed luminal cells and the transformed basal cells into mice.
In the meantime, though, the basal cell grafts had gone through three stages: They had grown into prostate-like tubules, transformed into damaged pre-cancerous cells, and then turned malignant and formed tumours.
"In our experimental model, basal cells show the ability to form the disease that looks like what we see in humans," says Goldstein.
The engrafted basal cells - after turning cancerous - also looked very much like luminal cells, as in clinical tumour samples. Witte says that this suggests that on their way to becoming cancerous, basal cells grow into more luminal-like cells.
The study has been unveiled in the July 30, 2010 issue of Science.
Source: ANI
Top Ten Facts About Prostate Cancer
This is the most controversial cancer in both treatment and diagnosis. Read interesting facts about this cancer.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/120x100/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Latest Cancer News
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
